Human H-ferritin presenting RBM of spike glycoprotein as potential vaccine of SARS-CoV-2
D. Yao, F. Lao, Z. Zhang, Y. Liu, J. Cheng, F. Ding, X. Wang, L. Xi, C. Wang, X. Yan, R. Zhang, F. Ouyang, H. Ding, T. Ke
This paper describes the design of a fusion protein using human ferritin to present the SARS-CoV-2 spike glycoprotein RBM, suggesting it as a potential vaccine candidate.
bioRxiv · May 25, 2020 · PreprintBioengineering